LYKA LABS
Back to Cashflow Statement
|
LYKA LABS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹5.29 Cr | ₹1.95 Cr | ₹-22 Cr | ₹-63 Cr | ₹-12 Cr |
What is the latest Cash Flow from Financing Activities ratio of LYKA LABS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹5.29 Cr |
| Mar2024 | ₹1.95 Cr |
| Mar2023 | ₹-22 Cr |
| Mar2022 | ₹-63 Cr |
| Mar2021 | ₹-12 Cr |
How is Cash Flow from Financing Activities of LYKA LABS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹5.29 Cr | 170.97 | |
| Mar2024 | ₹1.95 Cr | Positive | |
| Mar2023 | ₹-22 Cr | Negative | |
| Mar2022 | ₹-63 Cr | Negative | |
| Mar2021 | ₹-12 Cr | - | |
Compare Cash Flow from Financing Activities of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹215.9 Cr | 4% | 15.2% | -46.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹403,052.0 Cr | 0.3% | -3.7% | -4.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,336.0 Cr | 2.4% | 6.7% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,311.0 Cr | -0.8% | -1.5% | 25.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,264.0 Cr | 7.9% | 4.6% | 4.6% | Stock Analytics | |
| CIPLA | ₹105,484.0 Cr | 5.5% | 5.4% | -18.5% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | 4% |
15.2% |
-46.8% |
| SENSEX | -0.4% |
1.3% |
0.8% |
You may also like the below Video Courses